Indivior
Christian Heidbreder is the Chief Scientific Officer at Indivior, where Christian has pioneered the discovery, development, and regulatory approval of new pharmacotherapies in addiction medicine. Christian has also held various key roles in companies such as Reckitt, Altria, and GSK, where Christian led medications development programs for the treatment of psychiatric diseases. With a Ph.D. in Psychopharmacology, their extensive experience spans from academia to military service, making significant contributions to the fields of neuropsychopharmacology and behavioral neurochemistry.
This person is not in any offices